25- Hydroxyvitamin D Levels in Pregnancy and Effects on Pregnancy Related Disorders

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04637880

Acronym

VIDIS

Enrollment

249

Registered

2020-11-20

Start date

2012-07-31

Completion date

2018-07-01

Last updated

2020-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Gestational Hypertension, Preeclampsia, Preterm Delivery, Vitamin d Deficiency

Brief summary

Evaluation of 25- Hydroxyvitamin D levels in pregnant women in Austria and potential related disorders Hypothesis: Austrian pregnant women are Vitamin D deficient Present vitamin D supplementation in pregnancy is insufficient Vitamin D deficiency is associated with pregnancy related disorders like preeclampsia

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* age\> 18 years * informed consent

Exclusion criteria

* chronic hypertension * kidney disease * lupus erythematodes * diabetes mellitus * malabsorption syndrome * hyperparathyroidism * surgery on the thyroid gland

Design outcomes

Primary

Measure	Time frame
25- Hydroxyvitamin D and relation to development of preeclampsia	over course of pregnancy

Secondary

Measure	Time frame
25 Hydroxyvitamin D in newborn	once at delivery

Countries

Austria

Outcome results